Literature DB >> 11694327

Evidence of recurrent atypical meningioma with rhabdoid transformation and expression of pyrogenic cytokines in a child presenting with a marked acute-phase response: case report and review of the literature.

M Rittierodt1, T Tschernig, M Samii, G F Walter, A C Stan.   

Abstract

Children presenting with acute systemic illnesses that lack specific clinical or serological defining features may be diagnosed as having a chronic infection, an atypical systemic vasculitis or a connective tissue disease, but often turn out to have occult neoplasias. Cytokines have been implicated in causing many of the systemic effects in such cases. In this study, we describe the case of a 9-year-old boy presenting at an interval of 18 months with a marked acute-phase response due to a recurrent atypical meningioma with rhabdoid transformation of the tentorium cerebelli. Resection of the recurrent tumor was curative. We evaluated in detail the local and systemic production of cytokines released by the primary and the recurrent tumor. Blood and CSF samples were taken pre-, intra-, and postoperatively, and the production of IL-6, IL-1beta, and TNF-alpha was measured by enzyme-linked immunosorbent assays (ELISA). The level of IL-6 in CSF was about 150-fold increased before tumor resection, normalizing postoperatively. On the contrary, the levels of IL-1beta and TNF-alpha in CSF and of IL-6, IL-1beta, and TNF-alpha in serum were pre-, intra-, and postoperatively within normal limits. Cytokine production was also evaluated immunohistochemically, and confirmed strong IL-6 and TNF-alpha expression in the primary and the recurrent tumor, while expression of IL-1beta was lacking. The scattered MHC class II- and leukocyte common antigen (LCA)-expressing inflammatory cells, which were infiltrating exclusively the tumoral stroma, had no detectable cytokine immunoreactivity. We conclude that chronic IL-6 and TNF-alpha production by the tumor cells in this patient was responsible for the severe systemic illness with which he presented.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11694327     DOI: 10.1016/s0165-5728(01)00425-8

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  5 in total

1.  Intracerebral cystic rhabdoid papillary meningioma in an 11-year-old patient.

Authors:  Wenting Jia; Yukihiko Sonoda; Ryuta Saito; Toshiki Endo; Mika Watanabe; Teiji Tominaga
Journal:  Childs Nerv Syst       Date:  2014-06-21       Impact factor: 1.475

2.  Malignant rhabdoid tumor in a pregnant adult female: literature review of central nervous system rhabdoid tumors.

Authors:  Michelle L Erickson; Randall Johnson; Serguei I Bannykh; Alain de Lotbiniere; Jung H Kim
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

3.  Rhabdoid meningioma: a new subtype of malignant meningioma also apt to occur in children.

Authors:  Juan F Martínez-Lage; Belén Ferri Niguez; Joaquín Sola; Miguel A Pérez-Espejo; Javier Ros de San Pedro; Víctor Fernandez-Cornejo
Journal:  Childs Nerv Syst       Date:  2005-03-31       Impact factor: 1.475

Review 4.  Meningiomas With Rhabdoid Features Lacking Other Histologic Features of Malignancy: A Study of 44 Cases and Review of the Literature.

Authors:  Rachael A Vaubel; Selby G Chen; David R Raleigh; Michael J Link; Michael R Chicoine; Igor Barani; Sarah M Jenkins; Patrice Abell Aleff; Fausto J Rodriguez; Peter C Burger; Sonika Dahiya; Arie Perry; Caterina Giannini
Journal:  J Neuropathol Exp Neurol       Date:  2015-12-07       Impact factor: 3.685

5.  Primary calcified rhabdoid meningioma of the cranio-cervical junction: A case report and review of literature.

Authors:  Mohammad Abolfotoh; Daryoush Tavanaiepour; Changki Hong; Ian F Dunn; Hart Lidov; Ossama Al-Mefty
Journal:  J Craniovertebr Junction Spine       Date:  2012-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.